The Pharmalittle newsletter provides an overview of significant happenings in the pharmaceutical sector.
Among the highlights is a notable reversal by the FDA, which has implications for various stakeholders.
Additionally, the newsletter discusses the current wave of mergers and acquisitions within the industry, reflecting ongoing consolidation trends.